MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$48.80 2.13 (4.56%)
Open Price: 46.61
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients